COST Action CA18218

Publication of a burden-eu guide on calculating COVID-19 DALYs

Coronavirus disease 2019 (COVID‑19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), is an infectious disease for which the spread of disease was categorized as a pandemic by the World Health Organization in March 2020. The outbreak was first identified in December 2019 in Wuhan, China, and has since then spread globally. Estimating the burden of the disease at national level is useful for comparing its impact with other diseases in the population and across populations. Burden of disease studies quantify the health impact of diseases and risk factors in comparable metrics. The disability-adjusted life year (DALY) is one of the most used summary measure of population health, and the key metric in the Global Burden of Disease study.

The burden-eu Core Group has prepared a protocol to provide guidance for anyone planning to assess the burden of disease of COVID-19 at national level using DALYs. It focuses on the direct health impact of the disease, and describes the data requirements, the methods, and considerations for communicating results. It also aims to foster harmonization of methodologies for estimating the burden of disease of COVID-19 across countries.

You can download the protocol here.

The burden-eu COVID-19 resource page is available via

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini